U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: over 10,000 records

Showing results for "caused".

  1. Nrd 2010 Maskedstats Core V2 Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2010_MaskedStats_Core_V2_Weighted.PDF
    January 01, 2010 - blood cells 66,594 0.18% 64: Other hematologic conditions 5,041 0.01% 76: Meningitis (except that caused … by tuberculosis or sexually transmitted disease) 40,844 0.11% 77: Encephalitis (except that caused … 0.00% 89: Blindness and vision defects 5,823 0.02% 90: Inflammation; infection of eye (except that caused … Heart valve disorders 106,528 0.29% 97: Peri-; endo-; and myocarditis; cardiomyopathy (except that caused … 33,783 0.09% 121: Other diseases of veins and lymphatics 24,857 0.07% 122: Pneumonia (except that caused

  2. Nrd 2011 Maskedstats Core V2 (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2011_MaskedStats_Core_V2.PDF
    January 01, 2011 - blood cells 26,785 0.19% 64: Other hematologic conditions 2,089 0.02% 76: Meningitis (except that caused … by tuberculosis or sexually transmitted disease) 13,691 0.10% 77: Encephalitis (except that caused … 0.00% 89: Blindness and vision defects 2,432 0.02% 90: Inflammation; infection of eye (except that caused … Heart valve disorders 46,029 0.33% 97: Peri-; endo-; and myocarditis; cardiomyopathy (except that caused … 14,490 0.10% 121: Other diseases of veins and lymphatics 9,836 0.07% 122: Pneumonia (except that caused

  3. Nrd 2011 Maskedstats Core V2 Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2011_MaskedStats_Core_V2_Weighted.PDF
    January 01, 2011 - blood cells 68,998 0.19% 64: Other hematologic conditions 5,290 0.01% 76: Meningitis (except that caused … by tuberculosis or sexually transmitted disease) 37,085 0.10% 77: Encephalitis (except that caused … 0.00% 89: Blindness and vision defects 6,155 0.02% 90: Inflammation; infection of eye (except that caused … Heart valve disorders 111,701 0.30% 97: Peri-; endo-; and myocarditis; cardiomyopathy (except that caused … 33,620 0.09% 121: Other diseases of veins and lymphatics 24,216 0.07% 122: Pneumonia (except that caused

  4. Maskedstats Nrd 2015Q1Q3 Dx Pr Grps (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2015Q1Q3_Dx_Pr_Grps.PDF
    October 31, 2017 - blood cells 23,013 0.18% 64: Other hematologic conditions 1,969 0.02% 76: Meningitis (except that caused … by tuberculosis or sexually transmitted disease) 10,958 0.08% 77: Encephalitis (except that caused … 0.00% 89: Blindness and vision defects 2,176 0.02% 90: Inflammation; infection of eye (except that caused … Heart valve disorders 56,618 0.44% 97: Peri-; endo-; and myocarditis; cardiomyopathy (except that caused … 12,504 0.10% 121: Other diseases of veins and lymphatics 8,766 0.07% 122: Pneumonia (except that caused

  5. Nrd 2012 Maskedstats Core V2 Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2012_MaskedStats_Core_V2_Weighted.PDF
    January 01, 2012 - blood cells 68,969 0.19% 64: Other hematologic conditions 5,321 0.01% 76: Meningitis (except that caused … by tuberculosis or sexually transmitted disease) 34,128 0.09% 77: Encephalitis (except that caused … 0.00% 89: Blindness and vision defects 5,975 0.02% 90: Inflammation; infection of eye (except that caused … Heart valve disorders 120,954 0.33% 97: Peri-; endo-; and myocarditis; cardiomyopathy (except that caused … 33,989 0.09% 121: Other diseases of veins and lymphatics 23,835 0.07% 122: Pneumonia (except that caused

  6. Nrd 2012 Maskedstats Core V2 (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2012_MaskedStats_Core_V2.PDF
    January 01, 2012 - blood cells 25,538 0.19% 64: Other hematologic conditions 2,016 0.01% 76: Meningitis (except that caused … by tuberculosis or sexually transmitted disease) 12,312 0.09% 77: Encephalitis (except that caused … 0.00% 89: Blindness and vision defects 2,433 0.02% 90: Inflammation; infection of eye (except that caused … Heart valve disorders 49,165 0.37% 97: Peri-; endo-; and myocarditis; cardiomyopathy (except that caused … 14,282 0.11% 121: Other diseases of veins and lymphatics 9,569 0.07% 122: Pneumonia (except that caused

  7. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/84413/psn-pdf
    February 23, 2022 - A Loss of Trust and a Missed Diagnosis February 23, 2022 Landefeld J, Teasdale S, Jain S. A Loss of Trust and a Missed Diagnosis. PSNet [internet]. 2022. https://psnet.ahrq.gov/web-mm/loss-trust-and-missed-diagnosis Disclosure of Relevant Financial Relationships: As a provider accredited by the Accreditation Counci…

  8. Spotlight Case Hindsight Is 2020 Slides Final Revised 05.03.2024 (pdf file)

    psnet.ahrq.gov/sites/default/files/2024-05/spotlight_case_hindsight_is_2020_slides_final_revised_05.03.2024.pdf
    January 01, 2024 - Spotlight Hindsight is 20/20: Thrombolytics for Alcohol Intoxication Source and Credits • This presentation is based on the April 2024 AHRQ WebM&M Spotlight Case o See the full article at https://psnet.ahrq.gov/webmm o CME credit is available o Commentary by: Eric Signoff, MD, Noelle Boctor, MD, and David K. B…

  9. Final Progress Report: Addressing Preventable Medication Use Variance in Mississippi (pdf file)

    www.ahrq.gov/sites/default/files/2024-01/brown-report.pdf
    January 01, 2024 - Final Progress Report: Addressing Preventable Medication Use Variance in Mississippi FINAL PROGRESS REPORT Title of Project: Addressing Preventable Medication Use Variance in Mississippi Principal Investigator: Brown, CA, MD, MPH Team Members: William Rudman, PhD, Calvin Hewitt, MBA, Honey Holman, MD, Kent Kirchn…

  10. Presentation: Science of Improving Patient Safety and Identifying Defects

    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/surgery/modules/onboarding/onboarding_scienceofsafety_training.pptx
    December 01, 2017 - Presentation: Science of Improving Patient Safety and Identifying Defects The Science of Improving Patient Safety and Identifying Defects AHRQ Safety Program for Surgery Onboarding AHRQ Pub No. 16(18)-0004-15-EF December 2017 Science of Improving Patient Safety ‹#› AHRQ Safety Program for Surgery – …

  11. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/837959/psn-pdf
    August 31, 2022 - Perioperative Anaphylaxis After Insertion of a Latex Drain in a Patient with Known Latex Allergy August 31, 2022 Kelly KJ. Perioperative Anaphylaxis After Insertion of a Latex Drain in a Patient with Known Latex Allergy. PSNet [internet]. 2022. https://psnet.ahrq.gov/web-mm/perioperative-anaphylaxis-after-insertio…

  12. Recovering After Emergency Laparotomy (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/booklets/laparotomy-patient.pdf
    November 01, 2023 - Recovering After Emergency Laparotomy Recovering After Emergency Laparotomy e Emergency Laparotomy Patient Education Guide 1 Recovering After Emergency Laparotomy Patient Name ___________________________________________________________________ Surgeon Name ________________________________________________…

  13. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/49849/psn-pdf
    January 01, 2019 - These medications caused somnolence and drowsiness, so the patient was bedbound most of the day. … Fortunately, the vast majority (95%) of patient safety events caused minimal or no harm. … The most harmful events were self-harm (24% caused moderate harm) and adverse drug events (15% caused

  14. A Room Without Orders | PSNet

    psnet.ahrq.gov/web-mm/room-without-orders
    September 01, 2011 - immediately evaluated the patient and successfully treated him for symptomatic hypoglycemia, which had been caused

  15. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-insulin_executive.pdf
    September 01, 2008 - Layout 1 Background and Key Questions Although oral antidiabetic agents are used as first-line agents in patients with type 2 diabetes, insulin is required in a significant number of patients at some stage during the management of diabetes to maintain optimal glycemic control. Insulin use has been suggested as a fir…

  16. Changes in Pediatric Hospitalizations and In-Hospital Deaths in the Initial Period of the COVID-19 Pandemic (April–September 2020), 13 States (pdf file)

    hcup-us.ahrq.gov/reports/statbriefs/sb283-COVID-19-PediatricHosptl.pdf
    August 23, 2021 - Changes in Pediatric Hospitalizations and In-Hospital Deaths in the Initial Period of the COVID-19 Pandemic (April–September 2020), 13 States 1 HEALTHCARE COST AND UTILIZATION PROJECT Agency for Healthcare Research and Quality Changes in Pediatric Hospitalizations and In-Hospital Deaths in the Initial Period…

  17. AHRQ PSNet Annual Perspective: Impact of the COVID-19 Pandemic on Patient Safety | PSNet

    psnet.ahrq.gov/perspective/ahrq-psnet-annual-perspective-impact-covid-19-pandemic-patient-safety
    August 31, 2020 - Annual Perspective AHRQ PSNet Annual Perspective: Impact of the COVID-19 Pandemic on Patient Safety March 30, 2021  View more articles from the same authors. Citation Text: Stocking JC, Sandrock C, Fitall E, et al. AHRQ PSNet Annual Perspective: Impact of the…

  18. Primary Care Interventions to Prevent Child Maltreatment: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/DPq7_eawq-Ts6XLowaTaNA
    November 27, 2018 - Recognizing When a Child’s Injury or Illness Is Caused by Abuse: A Portable Guide to Investigating Child

  19. S81 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s81.pdf
    October 01, 2007 - ORIGINAL ARTICLE Developing Indicators of Inpatient Adverse Drug Events Through Nonlinear Analysis Using Administrative Data Jonathan R. Nebeker, MS, MD,*†‡§ Paul R. Yarnold, PhD,¶ Robert C. Soltysik, MS,� Brian C. Sauer, PhD,†‡ Shannon A. Sims, MD, MS,** Matthew H. Samore, MD,†‡§** Randall W. Rupper, MD, MPH,*†‡ Ka…

  20. Tools for Optimizing Medication Safety (TOP-MEDS) - 2012 | Digital Healthcare Research

    digital.ahrq.gov/ahrq-funded-projects/tools-optimizing-medication-safety-top-meds/annual-summary/2012
    January 01, 2012 - Tools for Optimizing Medication Safety (TOP-MEDS) - 2012 Project Name Tools for Optimizing Medication Safety (TOP-MEDS) Principal Investigator Lambert, Bruce Organization University of Illinois at Chicago Funding Mechanism RFA: HS11-004: Centers for Education and Re…
SHARE:
Facebook Twitter Print Facebook Share

Similar Terms:

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

psnet.ahrq.gov (8609)

www.ahrq.gov (3134)

effectivehealthcare.ahrq.gov (1740)

hcup-us.ahrq.gov (1067)

www.uspreventiveservicestaskforce.org (1000)

digital.ahrq.gov (735)

meps.ahrq.gov (86)

integrationacademy.ahrq.gov (49)

cds.ahrq.gov (37)

cdsic.ahrq.gov (21)

pso.ahrq.gov (17)

datatools.ahrq.gov (8)

qualityindicators.ahrq.gov (6)